Stability of parenteral nanoemulsions loaded with paclitaxel: the influence of lipid phase composition, drug concentration and storage temperature

• Published in: Pharmaceutical development and technology Vol. 19; no. 8; pp. 999 - 1004
• Main Authors: Kadam, Alisha N., Najlah, Mohammad, Wan, Ka-Wai, Ahmed, Waqar, Crean, St John, Phoenix, David A., Taylor, Kevin M. G., Elhissi, Abdelbary M. A.
• Format: Journal Article
• Language: English
• Published: England Informa Healthcare USA, Inc 01.12.2014; Taylor & Francis
• Subjects: Anticancer; Antineoplastic Agents, Phytogenic - administration & dosage; droplet size; Drug Stability; Drug Storage; emulsion; Emulsions - chemistry; Fat Emulsions, Intravenous - chemistry; paclitaxel; Paclitaxel - administration & dosage; Phospholipids - chemistry; Plant Oils - chemistry; Soybean Oil - chemistry; stability; Temperature; zeta potential
• ISSN: 1083-7450; 1097-9867
• DOI: 10.3109/10837450.2013.840845

Abstract Paclitaxel was loaded into licensed parenteral nutrition nanoemulsions (Clinoleic® and Intralipid®) using bath sonication, and the stability of the formulations was investigated following storage for two weeks at room temperature or at 4 °C. In general, Clinoleic droplets were smaller than Intralipid droplets, being around 255 and 285 nm, respectively, for blank and freshly loaded emulsions. Regardless of storage temperature, the Clinoleic exhibited a very slight or no increase in droplet size upon storage, whilst the droplet size of the Intralipid emulsion increased significantly. The droplet size of both emulsions was minimally affected by paclitaxel concentration within the range of 0, 1, 3 and 6 mg/ml. The pH of both emulsions markedly decreased upon storage at room temperature, which was possibly attributed to the production of fatty acids resulting from phospholipid hydrolysis. However, at 4 °C, the pH of Clinoleic emulsion was unaffected by storage or paclitaxel concentration while the Intralipid emulsion demonstrated a trend for pH reduction. Both nanoemulsions had a negative zeta potential, with the Clinoleic formulations having the highest charge, possibly explaining the better size stability of this emulsion. Overall, this study has shown that paclitaxel was successfully loaded into clinically licensed parenteral emulsions and that Clinoleic showed greater stability than the Intralipid.